Balwidx
You’ll find further details on NNZ-2591 preclinical data in the following sources
Preclinical data on the following can be found in the NNZ-2591 autism patent
Aging-related cognitive impairment, Aging-related memory loss, Fragile-X syndrome, Rett syndrome, ASDs, Stroke and Hypoxic Insults, Ballistic-like brain injury
https://patentscope.wipo.int/search/en/detail.jsf?docId=US295430762&_cid=P22-L92DJI-11253-5
Preclinical data on NNZ-2591 in Parkinson’s disease can be found in this NNZ-2591 patent
https://patentscope.wipo.int/search/en/detail.jsf?docId=US41587641&_cid=P22-L92ECU-21819-12
Reporting on NNZ-2591 testing in mouse model of Parkinson’s disease (Biospace, 2006)
https://www.biospace.com/article/re...rkinson-s-and-related-neurological-diseases-/
https://www.biospace.com/article/re...1-proves-effective-at-reversing-memory-loss-/
Neuren reporting of NNZ-2591 testing in Fragile-X (2013)
https://hotcopper.com.au/threads/ann-results-in-fragile-x-model-with-nnz-2591.2042462/
Neuren reporting of NNZ-2591 testing in animal models of multiple sclerosis (2014)
https://hotcopper.com.au/threads/ann-neuren-advances-nnz-2591-towards-ind-application.2336223/
Preclinical data on NNZ-2591 in Peripheral Neuropathy
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2011037644&_cid=P22-L92FBJ-36158-8
Share Price, page-2368
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.21 |
Change
-0.130(0.85%) |
Mkt cap ! $1.944B | |||
| Open | High | Low | Value | Volume |
| $15.19 | $15.47 | $15.07 | $6.450M | 422.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1938 | $15.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.29 | 54 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |